Skip to main navigation Skip to main content
  • KSBMR

JBM : Journal of Bone Metabolism

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

1
results for

"Arzu Jalilova"

Article category

Keywords

Publication year

Authors

"Arzu Jalilova"

Review Article

Efficacy of Bisphosphonate in Patients with Neurofibromatosis Type 1
Arzu Jalilova, Alessandra Cocca
J Bone Metab 2025;32(1):1-10.
Published online February 28, 2025
DOI: https://doi.org/10.11005/jbm.24.809
This review aims to synthesize current knowledge regarding the use of bisphosphonates (BPs) in the treatment of bone complications in patients with neurofibromatosis type 1 (NF1). NF1 is a genetic disorder marked by multiple benign tumors of the nervous system and various skeletal abnormalities, such as osteoporosis and an increased risk of fractures. BPs are drugs that inhibit bone resorption, commonly used to treat osteoporosis and other bone diseases. The review identified multiple studies examining the effects of BP therapy in NF1 patients. Most studies reported improvements in bone mineral density and reduced fracture occurrence. The most commonly reported side effects were mild gastrointestinal symptoms and transient musculoskeletal pain. However, the evidence is limited by the small number of studies and the heterogeneity of patient populations and treatment protocols. In conclusion, BPs show improvements in managing NF1 complications such as osteoporosis and a reduction of fracture risk in NF1 patients. While the existing studies suggest positive outcomes, there is a need for more rigorous, large-scale studies to establish standardized treatment protocols and long-term safety profiles. Healthcare providers should consider BP therapy as a potential option for NF1 patients with significant bone complications, while also monitoring for possible adverse effects.

Citations

Citations to this article as recorded by  Crossref logo
  • 1. Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling
    Jung Ha Kim, Semun Seong, Kabsun Kim, Inyoung Kim, Jeong-Tae Koh, Nacksung Kim
    Molecules and Cells.2026; 49(5): 100342.     CrossRef
  • 4,565 View
  • 90 Download
  • Crossref